Spigen Korea Co.,Ltd

KOSDAQ:A192440 Stock Report

Market Cap: ₩119.7b

Spigen KoreaLtd Balance Sheet Health

Financial Health criteria checks 6/6

Spigen KoreaLtd has a total shareholder equity of ₩489.4B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩533.8B and ₩44.4B respectively. Spigen KoreaLtd's EBIT is ₩24.9B making its interest coverage ratio -3.1. It has cash and short-term investments of ₩126.6B.

Key information

0%

Debt to equity ratio

₩0

Debt

Interest coverage ratio-3.1x
Cash₩126.60b
Equity₩489.41b
Total liabilities₩44.43b
Total assets₩533.84b

Recent financial health updates

Recent updates

Earnings Working Against Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share Price

Aug 08
Earnings Working Against Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share Price

Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In Value

Apr 13
Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In Value

Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Mar 30
Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 15
Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?

Mar 01
Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?

Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price Gain

Feb 16
Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price Gain

Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Feb 02
Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?

Jan 20
Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?

What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?

Jan 07
What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?

Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?

Dec 25
Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?

Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?

Dec 14
Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?

Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?

Dec 01
Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?

Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 17
Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Financial Position Analysis

Short Term Liabilities: A192440's short term assets (₩246.3B) exceed its short term liabilities (₩36.3B).

Long Term Liabilities: A192440's short term assets (₩246.3B) exceed its long term liabilities (₩8.2B).


Debt to Equity History and Analysis

Debt Level: A192440 is debt free.

Reducing Debt: A192440 has no debt compared to 5 years ago when its debt to equity ratio was 5.4%.

Debt Coverage: A192440 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: A192440 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies